← FDA Drug Approvals (Drugs@FDA)
OXALIPLATIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NOVAST LABS · Approved 2018-10-16
Drug application
- FDA Application #
ANDA207562- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- OXALIPLATIN
- Generic name
- Oxaliplatin
- Active ingredients
- OXALIPLATIN
- Dosage form
- INJECTABLE
- Route
- INTRAVENOUS
- Marketing status
- Discontinued
- Sponsor
- NOVAST LABS
- First approval
- 2018-10-16
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown